Our Director of Research, Dr Carol Routledge, looks back at some of the most exciting areas of progress in dementia research over the past 12 months. Dementia is a condition that has an enormous impact on millions of lives around the globe and a financial impact of over $1 trillion – more than the whole […]
With the recent announcement of a potential new Alzheimer’s drug showing promising results in late stage clinical trials, there has never been greater urgency to improve how we diagnose diseases like Alzheimer’s early and bring new treatment breakthroughs to people with dementia. Alzheimer’s Research UK’s Chief Medical Officer will help shape our emerging priority areas, […]
You may have seen exciting headlines about a possible new treatment for Alzheimer’s disease. But with so many stories about possible new dementia drugs making the news it can be difficult to know how significant these reports might be. What has happened? The Pharmaceutical company Biogen plans to file for US marketing approval for aducanumab, […]
At Alzheimer’s Research UK, we have the opportunity to talk to, work with and befriend many inspirational and passionate people. All too often, these people have personal experience of dementia – in fact 1 in 2 people know someone affected by dementia. They may not have a diagnosis themselves, but often they are carers, loved […]
Scientists have today announced results from the Football’s InfluencE on Lifelong Health and Dementia Risk (FIELD) study. This is the largest study to date looking back at the long-term health of professional football players, including their risk of dementia. The results will naturally raise questions from anyone interested in the sport, so here’s everything you […]
Each year as we finalise our Annual Report, I find myself reflecting on how far we’ve come. When the charity was established back in 1992 as the Alzheimer’s Research Trust, our founding trustees and scientists set out to fund a dedicated dementia research centre in Cambridge in response to a shocking lack of investment in […]
